148 related articles for article (PubMed ID: 3742469)
1. Correlation of female sex steroid hormone receptors with histologic and ultrastructural differentiation in adenocarcinoma of the endometrium.
Geisinger KR; Marshall RB; Kute TE; Homesley HD
Cancer; 1986 Oct; 58(7):1506-17. PubMed ID: 3742469
[TBL] [Abstract][Full Text] [Related]
2. An ultrastructural comparison of grade I and II endometrial adenocarcinoma considering estrogen and progesterone receptor status.
Horbelt DV; Freedman RS; Roberts DK; Walker NJ; Edwards CL; Jones LA
Gynecol Oncol; 1984 Jun; 18(2):150-6. PubMed ID: 6735260
[TBL] [Abstract][Full Text] [Related]
3. The distribution and prognostic implications of steroid receptors in endometrial carcinomas.
Utaaker E; Iversen OE; Skaarland E
Gynecol Oncol; 1987 Sep; 28(1):89-100. PubMed ID: 3653774
[TBL] [Abstract][Full Text] [Related]
4. Correlation of estrogen and progesterone receptors with histologic differentiation in endometrial adenocarcinoma.
McCarty KS; Barton TK; Fetter BF; Creasman WT; McCarty KS
Am J Pathol; 1979 Jul; 96(1):171-83. PubMed ID: 464018
[TBL] [Abstract][Full Text] [Related]
5. [Clinical importance of determining steroid hormone receptors in endometrial adenocarcinomas].
Avdeev VI; Kuz'mina ZV; Murav'eva NI; Bassalyk LS; Kozachenko VP
Vopr Onkol; 1987; 33(6):53-7. PubMed ID: 3617601
[TBL] [Abstract][Full Text] [Related]
6. Correlation between cytoplasmic steroid receptors and tumour differentiation and invasion in endometrial carcinoma.
Quinn MA; Pearce P; Fortune DW; Koh SH; Hsieh C; Cauchi M
Br J Obstet Gynaecol; 1985 Apr; 92(4):399-406. PubMed ID: 3986169
[TBL] [Abstract][Full Text] [Related]
7. Influence of cytoplasmic steroid receptor content on prognosis of early stage endometrial carcinoma.
Creasman WT; Soper JT; McCarty KS; McCarty KS; Hinshaw W; Clarke-Pearson DL
Am J Obstet Gynecol; 1985 Apr; 151(7):922-32. PubMed ID: 3985057
[TBL] [Abstract][Full Text] [Related]
8. Endometrial adenocarcinoma. A multiparameter clinicopathologic analysis including the DNA profile and the sex steroid hormone receptors.
Geisinger KR; Homesley HD; Morgan TM; Kute TE; Marshall RB
Cancer; 1986 Oct; 58(7):1518-25. PubMed ID: 3742470
[TBL] [Abstract][Full Text] [Related]
9. Correlation of estrogen and progesterone receptors with histologic differentiation in mammary carcinoma.
McCarty KS; Barton TK; Fetter BF; Woodard BH; Mossler JA; Reeves W; Daly J; Wilkinson WE; McCarty KS
Cancer; 1980 Dec; 46(12 Suppl):2851-8. PubMed ID: 6256054
[TBL] [Abstract][Full Text] [Related]
10. Cytoplasmic progesterone and estradiol receptors in normal, hyperplastic, and carcinomatous endometria: therapeutic implications.
Ehrlich CE; Young PC; Cleary RE
Am J Obstet Gynecol; 1981 Nov; 141(5):539-46. PubMed ID: 6457531
[TBL] [Abstract][Full Text] [Related]
11. Clinical correlates of estrogen- and progesterone-binding proteins in human endometrial adenocarcinoma.
Creasman WT; McCarty KS; Barton TK; McCarty KS
Obstet Gynecol; 1980 Mar; 55(3):363-70. PubMed ID: 7189047
[TBL] [Abstract][Full Text] [Related]
12. Study of estrogen receptor, progesterone receptor, and the estrogen-regulated Mr 24,000 protein in patients with carcinomas of the endometrium and cervix.
Ciocca DR; Puy LA; Fasoli LC
Cancer Res; 1989 Aug; 49(15):4298-304. PubMed ID: 2743317
[TBL] [Abstract][Full Text] [Related]
13. Cytoplasmic estrogen and progesterone receptors as prognostic parameters in primary endometrial carcinoma.
Liao BS; Twiggs LB; Leung BS; Yu WC; Potish RA; Prem KA
Obstet Gynecol; 1986 Apr; 67(4):463-7. PubMed ID: 3960417
[TBL] [Abstract][Full Text] [Related]
14. Estrogen and progesterone receptors in endometrial cancer and their prognostic relevance.
Kleine W; Maier T; Geyer H; Pfleiderer A
Gynecol Oncol; 1990 Jul; 38(1):59-65. PubMed ID: 2141316
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the relationships of the ploidy and cell cycle kinetics to differentiation and the female sex steroid hormone receptors in adenocarcinoma of the endometrium.
Geisinger KR; Kute TE; Marshall RB; Homesley HD; Morgan TM
Am J Clin Pathol; 1986 May; 85(5):536-41. PubMed ID: 3706195
[TBL] [Abstract][Full Text] [Related]
16. Endometrial cancer: histologic correlates of immunohistochemical localization of progesterone receptor and estrogen receptor.
Segreti EM; Novotny DB; Soper JT; Mutch DG; Creasman WT; McCarty KS
Obstet Gynecol; 1989 May; 73(5 Pt 1):780-5. PubMed ID: 2704506
[TBL] [Abstract][Full Text] [Related]
17. Steroid receptors and clinical outcome in patients with adenocarcinoma of the endometrium.
Ehrlich CE; Young PC; Stehman FB; Sutton GP; Alford WM
Am J Obstet Gynecol; 1988 Apr; 158(4):796-807. PubMed ID: 2966586
[TBL] [Abstract][Full Text] [Related]
18. [Correlation between estrogen receptor(ER), progesterone receptor(PR) and human keratin protein (hKP) in endometrial carcinoma].
Hatae M; Yagi Y
Gan No Rinsho; 1983 Dec; 29(15):1740-9. PubMed ID: 6199529
[TBL] [Abstract][Full Text] [Related]
19. Morphology of human uterine cancer in nude mice. Effects of hormone and antihormone treatment.
Zaino RJ; Satyaswaroop PG; Mortel R
Arch Pathol Lab Med; 1984 Jul; 108(7):571-8. PubMed ID: 6547322
[TBL] [Abstract][Full Text] [Related]
20. [Study of estrogen and progesterone receptors in endometrial carcinoma].
Chen Y; Peng Z
Hua Xi Yi Ke Da Xue Xue Bao; 2000 Mar; 31(1):98-100. PubMed ID: 12501628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
